Main Library

Value-Based Primary Care Providers Try New Strategies to Improve Population Health

December 15, 2022Allison InserroAJMCBest Practices & Strategies for Success,Hospice & Palliative Care,Population Health,Dementia & Alzheimers

Cognitive concerns frequently show up in primary care as adults age, although not all memory loss will progress to the dysfunction of dementia. However, the number of Americans with diagnosed Alzheimer disease (AD) could grow to nearly 14 million by 2060, up from 6.5 million currently.1

To halt that trend, much of the recent focus has been on the success or failure of drugs to slow the progression of this devastating neurological disease, most notably the FDA’s controversial 2021 approval of aducanumab, a monoclonal antibody, or results of lecanemab, another biologic, which slowed cognitive decline for patients in the early stage of disease but, as with aducanumab, was linked with brain swelling and bleeding.2

If no viable disease-modifying treatment options appear, the time-starved primary care provider (PCP) will continue to see these patients and families first as AD cases surge in coming decades.

Full Article

Recent Posts

  • CMS Commits to Control Total Cost of Care: 6 Volleys in the 2026 CMS PFS Proposed Rule
  • Making Value-Based Payment The Best Choice For Providers
  • Value-based care’s blind spot: The missing link few are talking about
  • CMS proposes rule aligning Medicare physician payment with ‘Big Beautiful Bill,’ MACRA
  • How ASCs can reach their value-based care goals
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us